October 5th, 2021
12:00 PM - 1:00 PM EDT
In this webinar, we’ll discuss what we know about FDA regulation of cannabis and cannabis-derived products and look at trends in recent FDA enforcement over CBD products.
Topics include:
- Pathways for FDA authorization of cannabis and other cannabis-derived products, including CBD
- New Drugs
- New Dietary Ingredient Notification – Foods/Dietary Supplements
- New Animal Foods/Drugs
- What other cannabinoids are of commercial interest
- Other legal concerns around marketing cannabinoids
Speakers:
CPD points 1.00 General credit hour pending in CA/DE/GA/NC/SC/TX/VA